On June 25, the White House announced an initiative to encourage greater transparency in drug pricing. President Trump signed an Executive Order on June 25, entitled “Improving Price and Quality Transparency in American Healthcare to Put Patients First.”

The purpose of the order is to direct federal agencies to issue regulations to improve the transparency of health care prices and quality in order to create a more competitive marketplace and provide consumers with the information they need to make informed purchasing decisions.  More specifically, the executive order:

Read the Full Transcript of the Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First.

Read the Factsheet – Healthcare Price Transparency Final.

Contact Us